TLC BioSciences Corp. (TPEX:7924)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
250.50
-12.50 (-4.75%)
At close: Jul 8, 2026
Market Cap33.46B
Revenuen/a
Net Incomen/a
EPSn/a
Shares Out 133.56M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume428,437
Open260.00
Previous Close263.00
Day's Range246.00 - 265.00
52-Week Range163.00 - 300.00
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About TLC BioSciences

TLC BioSciences Corp. operates as a clinical-stage biotechnology company that develops and sells lipid-engineered medicines in Taiwan, the United States of America, Europe, and the Cayman Islands. It offers products based on its proprietary LipAD, a drug delivery platforms, including BioSeizer for sustained release; NanoX for targeted delivery; and Genosphere for regenerative medicine. The company's pipeline includes candidates for orthopedics and pain management, metabolic and immune disorders, and infectious diseases. The company was founded ... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1997
Country Cayman Islands
Stock Exchange Taipei Exchange
Ticker Symbol 7924
Full Company Profile